Journal of cardiothoracic and vascular anesthesia
-
J. Cardiothorac. Vasc. Anesth. · Feb 2000
Total intravenous anesthesia with ketamine for pediatric interventional cardiac procedures.
To evaluate the safety and efficacy of ketamine in pediatric patients undergoing interventional cardiac procedures. ⋯ The technique described is a simple, safe, and effective method for anesthetizing children in the cardiac catheterization laboratory for interventional procedures.
-
J. Cardiothorac. Vasc. Anesth. · Feb 2000
Respiratory jugular venodilation: a new landmark for right internal jugular vein puncture in ventilated patients.
To report a new technique for right internal jugular vein puncture using respiratory jugular venodilation as a landmark for vein location. ⋯ Respiratory jugular venodilation can be identified in a large proportion of ventilated patients. This experience suggests that respiratory jugular venodilation could be favorably used as the primary landmark for right internal jugular vein puncture in anesthetized patients.
-
J. Cardiothorac. Vasc. Anesth. · Feb 2000
Assessment of systematic use of intraoperative transesophageal echocardiography during cardiac surgery in adults: a prospective study of 203 patients.
To determine the usefulness of systematic intraoperative transesophageal echocardiography in a cardiac surgical unit. ⋯ It is concluded that systematic intraoperative transesophageal echocardiography significantly affected decision making in this cardiac surgical unit. Its routine use in all cardiac surgical patients is recommended.
-
J. Cardiothorac. Vasc. Anesth. · Dec 1999
Randomized Controlled Trial Clinical TrialA randomized, blinded trial of the antioxidant pegorgotein: no reduction in neuropsychological deficits, inotropic drug support, or myocardial ischemia after coronary artery bypass surgery.
To determine whether patients receiving pegorgotein preoperatively would be less likely than patients receiving placebo to demonstrate postoperative cerebral or myocardial dysfunction and thus would be less likely to (1) demonstrate a decline in neuropsychologic testing after cardiopulmonary bypass, (2) receive inotropic drug support, or (3) demonstrate electrocardiographic signs of ischemia or infarction. ⋯ This study showed no positive influence of pegorgotein on the incidence of any of the findings and showed a trend toward an increased incidence of myocardial ischemia or infarction.